Center for Radiopharmaceutical Sciences, Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Zurich, Zurich, Switzerland; and.
Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland.
J Nucl Med. 2024 Feb 1;65(2):300-305. doi: 10.2967/jnumed.123.266426.
This study aimed to evaluate ()-[F]YH134 as a novel PET tracer for imaging monoacylglycerol lipase (MAGL). Considering the ubiquitous expression of MAGL throughout the whole body, the impact of various MAGL inhibitors on ()-[F]YH134 brain uptake and its application in brain-periphery crosstalk were explored. MAGL knockout and wild-type mice were used to evaluate ()-[F]YH134 in in vitro autoradiography and PET experiments. To explore the impact of peripheral MAGL occupancy on ()-[F]YH134 brain uptake, PET kinetics with an arterial input function were studied in male Wistar rats under baseline and blocking conditions. In in vitro autoradiography, ()-[F]YH134 revealed a heterogeneous distribution pattern with high binding to MAGL-rich brain regions in wild-type mouse brain slices, whereas the radioactive signal was negligible in MAGL knockout mouse brain slices. The in vivo brain PET images of ()-[F]YH134 in wild-type and MAGL knockout mice demonstrated its high specificity and selectivity in mouse brain. A Logan plot with plasma input function was applied to estimate the distribution volume ( ) of ()-[F]YH134. was significantly reduced by a brain-penetrant MAGL inhibitor but was unchanged by a peripherally restricted MAGL inhibitor. The MAGL target occupancy in the periphery was estimated using ()-[F]YH134 PET imaging data from the brain. ()-[F]YH134 is a highly specific and selective PET tracer with favorable kinetic properties for imaging MAGL in rodent brain. Our results showed that blocking of the peripheral target influences brain uptake but not the of ()-[F]YH134. ()-[F]YH134 can be used for estimating the dose of MAGL inhibitor at half-maximal peripheral target occupancy.
本研究旨在评估 ()-[F]YH134 作为一种新型的单酰基甘油脂肪酶 (MAGL) 的 PET 示踪剂。考虑到 MAGL 在全身的广泛表达,研究了各种 MAGL 抑制剂对 ()-[F]YH134 脑摄取的影响及其在脑-外周串扰中的应用。使用 MAGL 敲除和野生型小鼠进行体外放射自显影和 PET 实验评估 ()-[F]YH134。为了探讨外周 MAGL 占有率对 ()-[F]YH134 脑摄取的影响,在雄性 Wistar 大鼠中,在基线和阻断条件下,使用动脉输入函数研究了 PET 动力学。在体外放射自显影中,()-[F]YH134 显示出与野生型小鼠脑切片中富含 MAGL 的脑区具有高结合的异质分布模式,而在 MAGL 敲除小鼠脑切片中放射性信号可以忽略不计。在野生型和 MAGL 敲除小鼠的体内脑 PET 图像中,()-[F]YH134 表现出其在小鼠脑中的高特异性和选择性。使用血浆输入函数的 Logan 图来估计 ()-[F]YH134 的分布容积 ( )。脑穿透性 MAGL 抑制剂显著降低了 ,而外周受限的 MAGL 抑制剂则没有改变。使用来自大脑的 ()-[F]YH134 PET 成像数据来估计外周的 MAGL 靶标占有率。()-[F]YH134 是一种具有良好动力学特性的高特异性和选择性 PET 示踪剂,可用于在啮齿动物脑中成像 MAGL。我们的研究结果表明,外周靶标的阻断会影响脑摄取,但不会影响 ()-[F]YH134 的 。()-[F]YH134 可用于估计在最大外周靶标占有率的一半时 MAGL 抑制剂的剂量。